Vaccines
COVID-19: United Kingdom Approves “Double” Vac
COVID-19: United Kingdom Approves “Double” Vaccine

Protects Against the Original Wuhan Form of the SARS-CoV-2 Virus and the First Omicron Variant (BA. 1). They Estimate That the First Doses Could Be Applied at the End of September

April 2023

Needle-Free Nasal COVID-19 Vaccine Shows Promise
Needle-Free Nasal COVID-19 Vaccine Shows Promise

A highly effective, needle- and adjuvant-free, bacteriophage-based mucosal COVID-19 vaccine demonstrates potential as an alternative vaccination approach.

April 2023

COVID Vaccination Linked to Reduced Risk of Acute
COVID Vaccination Linked to Reduced Risk of Acute Myocardial Infarction and Stroke

Evidence suggests an association between COVID vaccination and reduced incidence of acute myocardial infarction and ischemic stroke following COVID-19 infection.

April 2023

Needle-Free Nasal Vaccine to Prevent COVID-19 Infe
Needle-Free Nasal Vaccine to Prevent COVID-19 Infection

Tixagevimab-cilgavimab, a combination medicine, offers a needle-free option for preventing COVID-19 infection.

March 2023

FDA Approves Method to Vaccinate More People Again
FDA Approves Method to Vaccinate More People Against Monkeypox

The US Endorsed the Emergency Use of the JYNNEOS Vaccine Intradermally for Those over 18 Years of Age in High. This Route Requires Less Product with Similar Benefits, According to a Previous Study

March 2023

FDA Authorizes Emergency Use of Novavax COVID-19 V
FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine

The FDA grants emergency use authorization for the Novavax COVID-19 vaccine, available for individuals aged 18 years and older in a two-dose regimen, containing Spike protein and Matrix-M adjuvant.

March 2023

EMA Authorized Technique to Vaccinate More People
EMA Authorized Technique to Vaccinate More People Against Monkeypox

He Endorsed the Intradermal Administration of the Imvanex Vaccine, Which Offers Similar Antibodies with One-fifth the Dose

March 2023

Global Preparedness Strategies for Rising Monkeypo
Global Preparedness Strategies for Rising Monkeypox Cases, Focus on Latin America

Countries like the US implement proactive strategies involving vaccine distribution and expanded testing to address rising monkeypox cases, prompting inquiries into the distribution of cases across Latin America and the need for regional response efforts.

March 2023

WHO Reports 61 Vaccines in Development for Drug-Re
WHO Reports 61 Vaccines in Development for Drug-Resistant Bacterial Diseases

Despite promising advancements, the World Health Organization (WHO) emphasizes the ongoing need to enhance existing vaccine utilization as 61 potential vaccines for drug-resistant bacterial diseases are under development, albeit not immediately available.

March 2023

FDA Recommends Modification of Vaccines to Include
FDA Recommends Modification of Vaccines to Include Omicron BA 4/5 Component

The FDA advises the inclusion of an Omicron BA 4/5 spike protein component in COVID-19 vaccines, prompting efforts to develop modified vaccine formulations to enhance protection against emerging variants of concern.

March 2023

Allergies Artificial Intelligence Cancer Cardiovascular Child care Covid Diabetes Drugs Exercising Food & Health Hypertension Microbiology Neurology Obstetrics Ophtalmology Oral health Respiratory Skin care Sleep Smoking Surgery Vaccines Women's health
Top reads...
Reevaluating Sunlight Exposure New Study Unveils Effective TB Prevention Strategy Smoking, Alcohol Consumption, and Risk of Incident Diverticulitis Rotator cuff surgery Differences in the Top 20 Causes of Illness Between Men and Women